PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 10, 2026International Journal of Gynecology & Obstetrics0 citations

Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone ( GnRH ) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation ( EMV / AVM ) and retained products of conception ( RPOC ): A retrospective cohort study

View Full Paper
AFAmin Abolhasani ForoughiSDSeyed Sina DehghaniZSZahra Shiravani

Key Points

  • The study aims to compare the effectiveness of curettage, UAE, and GnRH agonist therapy in treating specific uterine conditions.
  • Retrospective cohort study design
  • Compared three treatment modalities: curettage, UAE, and GnRH agonist therapy
  • Evaluated short-term healing and reproductive outcomes
  • Considered Doppler parameters and clinical stability in treatment selection
  • Curettage and UAE showed superior short-term healing compared to GnRH agonist therapy
  • Reproductive outcomes were comparable across all treatment modalities
  • Doppler parameters and clinical stability are important factors in treatment selection

Abstract

Curettage and UAE provide superior short-term healing compared with GnRH agonist therapy, while reproductive outcomes appear comparable across modalities. Treatment selection should consider Doppler parameters, clinical stability, and fertility goals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Foroughi et al. (2026) studied this question.

synapsesocial.com/papers/69d896046c1944d70ce073cahttps://doi.org/10.1002/ijgo.71010
Ask AI
Helpful
Bookmark
Share
View Full Paper